UBS analysts upgraded Clorox (NYSE: CLX) to neutral from Sell, raising the price target for the stock to $132 from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE